Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Caribou Biosciences, Inc.

NASDAQ: CRBU · Life Sciences · 3 alerts · CIK 1619856

Share price
$0.3528Close, Nov 16
Market cap
$38.1M
Shares outstanding
108.04MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Caribou Biosciences, Inc. filings on SEC EDGAR ↗

4:07 PM ET 8-K
Business Update

Caribou Biosciences Business Update

Caribou Biosciences is exploring strategic alternatives and implementing a restructuring plan that includes discontinuing its allogeneic CAR-T cell therapy programs, vispa-cel and CB-011. The company is conducting a substantial workforce reduction and expects to incur restructuring charges between $15 million and $19 million, primarily for severance and clinical trial wind-down costs.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.